![Immunocytochemistry/Immunofluorescence: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with HEK293 human embryonic kidney cells.](http://images.novusbio.com/fullsize/Cannabinoid-R1-CB1-CNR1-Antibody-Immunocytochemistry-Immunofluorescence-NLS32-img0007.jpg "Immunocytochemistry/Immunofluorescence: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with HEK293 human embryonic kidney cells.")
| Reactivity | Hu, Mu, Rt, Po, Bt, Bv, Ca, Eq, Pm, Pm, Pm, FeSpecies Glossary |
| Applications | ICC/IF, IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 1.0 mg/ml |
| Description | Product can be stored undiluted at 4C for up to 1 month. |
| Immunogen | Synthetic 16 amino acid peptide from C-terminus of human Cannabinoid R1/CB1/CNR1. |
| Epitope | C-Terminus |
| Localization | Cell membrane; Multi-pass membrane protein. |
| Specificity | Human Cannabinoid R1/CB1/CNR1. BLAST analysis of the peptide immunogen showed no homology with other human proteins. |
| Predicted Species | Chimpanzee (100%), Feline (100%). Backed by our 100% Guarantee. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | CNR1 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
| Application Notes | . |
| Storage | Keep as concentrated solution. Aliquot and store at -20C or below. Avoid multiple freeze-thaw cycles. |
| Buffer | PBS |
| Preservative | 0.1% Sodium Azide |
| Concentration | 1.0 mg/ml |
| Purity | Immunogen affinity purified |
Secondary Antibodies |
Isotype Controls |
Research Areas for Cannabinoid R1/CB1/CNR1 Antibody (NLS32)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Brain, substantia nigra](http://images.novusbio.com/fullsize/Cannabinoid-R1-CB1-CNR1-Antibody-Immunohistochemistry-Paraffin-NLS32-img0013.jpg "Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Brain, substantia nigra")
![Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with brain, neuron.](http://images.novusbio.com/fullsize/Cannabinoid-R1-CB1-CNR1-Antibody-Immunohistochemistry-Paraffin-NLS32-img0008.jpg "Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with brain, neuron.")
![Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with untransfected HEK293 human embryonic kidney cells.](http://images.novusbio.com/fullsize/Cannabinoid-R1-CB1-CNR1-Antibody-Immunohistochemistry-Paraffin-NLS32-img0010.jpg "Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with untransfected HEK293 human embryonic kidney cells.")
![Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with human brain, glioblastoma.](http://images.novusbio.com/fullsize/Cannabinoid-R1-CB1-CNR1-Antibody-Immunohistochemistry-Paraffin-NLS32-img0011.jpg "Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Analysis of anti-CNR1 / CB1 antibody with human brain, glioblastoma.")
![Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Anti-CNR1 / CB1 antibody IHC of human Lymph Node, Non-Hodgkins Lymphoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Cannabinoid-R1-CB1-CNR1-Antibody-Immunohistochemistry-Paraffin-NLS32-img0012.jpg "Immunohistochemistry-Paraffin: Cannabinoid R1/CB1/CNR1 Antibody [NLS32] - Anti-CNR1 / CB1 antibody IHC of human Lymph Node, Non-Hodgkins Lymphoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.")
![Immunocytochemistry Insulin Antibody (182410) [Unconjugated]](https://images.novusbio.com/images2/Insulin_MAB1417_Immunocytochemistry_9376.jpg)
![Immunohistochemistry Insulin Antibody (182410) [Unconjugated]](https://images.novusbio.com/images2/mab1417_human-bovine-mouse-insulin-mab-clone-182410-immunohistochemistry-308202115145.jpg)
![Western Blot ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Western_Blot_5097.jpg)
![Immunohistochemistry ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Immunohistochemistry_20696.jpg)
![Knockout Validated ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Knockout_Validated_22864.jpg)
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
![N/A Adiponectin/Acrp30 [HRP]](https://images.novusbio.com/images2/DATA_Adiponectin_DRP300_ELISA_812.jpg)
![N/A Adiponectin/Acrp30 [HRP]](https://images.novusbio.com/images2/DATA_Adiponectin_DRP300_ELISA_813.jpg)
![N/A Adiponectin/Acrp30 [HRP]](https://images.novusbio.com/images2/Adiponectin_DRP300_ELISA_173.jpg)
![N/A Leptin/OB [HRP]](https://images.novusbio.com/images2/Leptin_DLP00_ELISA_134.jpg)
![N/A Leptin/OB [HRP]](https://images.novusbio.com/images2/DATA_Leptin_DLP00_ELISA_749.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")